304 related articles for article (PubMed ID: 25800274)
61. Pathogen-Specific T Cell Polyfunctionality Is a Correlate of T Cell Efficacy and Immune Protection.
Boyd A; Almeida JR; Darrah PA; Sauce D; Seder RA; Appay V; Gorochov G; Larsen M
PLoS One; 2015; 10(6):e0128714. PubMed ID: 26046523
[TBL] [Abstract][Full Text] [Related]
62. [CD8+ cytotoxic lymphocytes in cutaneous leishmaniasis].
Hernández-Ruiz J; Becker I
Salud Publica Mex; 2006; 48(5):430-9. PubMed ID: 17063826
[TBL] [Abstract][Full Text] [Related]
63. Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.
Cardoso TM; Machado Á; Costa DL; Carvalho LP; Queiroz A; Machado P; Scott P; Carvalho EM; Bacellar O
Infect Immun; 2015 Mar; 83(3):898-906. PubMed ID: 25534940
[TBL] [Abstract][Full Text] [Related]
64. Could the lower frequency of CD8+CD18+CD45RO+ lymphocytes be biomarkers of human VL?
Clarêncio J; de Oliveira CI; Favali C; Medina O; Caldas A; Costa CH; Costa DL; Brodskyn C; Barral A; Barral-Netto M
Int Immunol; 2009 Feb; 21(2):137-44. PubMed ID: 19088063
[TBL] [Abstract][Full Text] [Related]
65. Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi.
Reis AB; Teixeira-Carvalho A; Giunchetti RC; Guerra LL; Carvalho MG; Mayrink W; Genaro O; Corrêa-Oliveira R; Martins-Filho OA
Clin Exp Immunol; 2006 Nov; 146(2):303-11. PubMed ID: 17034583
[TBL] [Abstract][Full Text] [Related]
66. Cross-presenting dendritic cells are required for control of Leishmania major infection.
Ashok D; Schuster S; Ronet C; Rosa M; Mack V; Lavanchy C; Marraco SF; Fasel N; Murphy KM; Tacchini-Cottier F; Acha-Orbea H
Eur J Immunol; 2014 May; 44(5):1422-32. PubMed ID: 24643576
[TBL] [Abstract][Full Text] [Related]
67. IL2RA genetic variants reduce IL-2-dependent responses and aggravate human cutaneous leishmaniasis.
Oliveira PR; Dessein H; Romano A; Cabantous S; de Brito ME; Santoro F; Pitta MG; Pereira V; Pontes-de-Carvalho LC; Rodrigues V; Rafati S; Argiro L; Dessein AJ
J Immunol; 2015 Mar; 194(6):2664-72. PubMed ID: 25672756
[TBL] [Abstract][Full Text] [Related]
68. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
White KL; Snyder HL; Krzych U
J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
[TBL] [Abstract][Full Text] [Related]
69. Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure.
Brelaz-de-Castro MC; de Almeida AF; de Oliveira AP; de Assis-Souza M; da Rocha LF; Pereira VR
Cell Immunol; 2012 Oct; 279(2):180-6. PubMed ID: 23246680
[TBL] [Abstract][Full Text] [Related]
70. Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells.
Uzonna JE; Joyce KL; Scott P
J Exp Med; 2004 Jun; 199(11):1559-66. PubMed ID: 15184505
[TBL] [Abstract][Full Text] [Related]
71. CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection.
Rosas LE; Barbi J; Lu B; Fujiwara Y; Gerard C; Sanders VM; Satoskar AR
Eur J Immunol; 2005 Feb; 35(2):515-23. PubMed ID: 15668916
[TBL] [Abstract][Full Text] [Related]
72. Early CD44(hi)CD4+ and CD44(hi)CD8+ T cell numbers and the absence of mannose-rich glycoconjugates determine the protective outcome of anti-leishmanial immunity.
Kedzierski L; Curtis JM; Kedzierska K
Parasitology; 2009 Jul; 136(8):833-40. PubMed ID: 19490731
[TBL] [Abstract][Full Text] [Related]
73. Cutaneous Leishmaniasis: The Complexity of Host's Effective Immune Response against a Polymorphic Parasitic Disease.
Gabriel Á; Valério-Bolas A; Palma-Marques J; Mourata-Gonçalves P; Ruas P; Dias-Guerreiro T; Santos-Gomes G
J Immunol Res; 2019; 2019():2603730. PubMed ID: 31871953
[TBL] [Abstract][Full Text] [Related]
74. Mobilizing unconventional T cells.
Ottenhoff THM; Joosten SA
Science; 2019 Oct; 366(6463):302-303. PubMed ID: 31624196
[No Abstract] [Full Text] [Related]
75. Regulation of CD8+ T cell responses to infection with parasitic protozoa.
Jordan KA; Hunter CA
Exp Parasitol; 2010 Nov; 126(3):318-25. PubMed ID: 20493842
[TBL] [Abstract][Full Text] [Related]
76. CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists.
Hernández-Ruiz J; Salaiza-Suazo N; Carrada G; Escoto S; Ruiz-Remigio A; Rosenstein Y; Zentella A; Becker I
PLoS Negl Trop Dis; 2010 Nov; 4(11):e871. PubMed ID: 21072232
[TBL] [Abstract][Full Text] [Related]
77. Interleukin-27 Functional Duality Balances
Jafarzadeh A; Nemati M; Chauhan P; Patidar A; Sarkar A; Sharifi I; Saha B
Front Immunol; 2020; 11():1573. PubMed ID: 32849534
[TBL] [Abstract][Full Text] [Related]
78. Memory T cells in cutaneous leishmaniasis.
Glennie ND; Scott P
Cell Immunol; 2016 Nov; 309():50-54. PubMed ID: 27493096
[TBL] [Abstract][Full Text] [Related]
79. The role of CD8 T lymphocytes in rickettsial infections.
Walker DH; Dumler JS
Semin Immunopathol; 2015 May; 37(3):289-99. PubMed ID: 25823954
[TBL] [Abstract][Full Text] [Related]
80. Cellular immune responses to Leishmania braziliensis in patients with AIDS-associated American cutaneous leishmaniasis.
Da-Cruz AM; Mattos M; Oliveira-Neto MP; Coutinho Z; Machado ES; Coutinho SG
Trans R Soc Trop Med Hyg; 2000; 94(5):569-71. PubMed ID: 11132391
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
